Mouse cationic amino acid transporter 1 (mCAT1) serves as the receptor for ecotropic murine leukemia virus (eMuLV). It has been shown that mCAT1 is expressed on the basolateral surface of polarized epithelial MDCK cells. However, little is known about the mechanisms involved in the intracellular trafficking of mCAT1. Using the green fluorescent protein-tagged mCAT1 expressed in MDCK cells, we report here that mCAT1 is physically associated with clathrin adaptor protein complex 1 (AP-1) implicated in protein trafficking from trans-Golgi network (TGN) to the basolateral surface. When the cells were infected with eMuLV, reduction of cell surface mCAT1, as well as a concomitant decrease in mCAT1-AP-1 association, was observed while association of mCAT1 with AP-3 involved in the TGN-to-lysosome trafficking was increased. Similar results were obtained when eMuLV envelope protein alone was expressed. The results may provide useful insights into the mechanism by which a simple retrovirus downregulates its receptor.
Introduction
Mammalian cells express amino acid transporters of distinct systems, such as y + , y + L, b 0,+ , and B 0,+ . As for system y + , four proteins, cationic amino acid transporters (CAT) 1 through 4, have been identified. Among these, CAT1 is involved in sodiumindependent transport of arginine, lysine, and histidine and was originally identified as the membrane receptor of mouse cells for ecotropic murine leukemia viruses (eMuLVs) (Albritton et al., 1989; Kim et al., 1991; Wang et al., 1991) . Deduced amino acid sequence of CAT1 suggests that it is a single polypeptide of 622 amino acids with 14 membrane spanning domains (Albritton et al., 1989) . Detailed cell biological studies on CAT1 protein have not been carried out extensively partly because it is difficult to raise a specific antibody against this protein. Therefore, little is known about posttranslational regulation of CAT1 expression. It has previously been shown that green fluorescent protein (GFP)-tagged mouse CAT1 (mCAT1) retains eMuLV receptor activity and that the fusion molecule (mCAT1-GFP) is useful for immunological detection and visualization of the subcellular localization (Kizhatil and Albritton, 2003; Masuda et al., 1999) . Using the GFP fusion strategy, Kizhatil and Albritton (2003) have also demonstrated that mCAT1 is expressed on the basolateral plasma membrane of polarized epithelial cells (Kizhatil and Albritton, 2003) . However, the mechanism responsible for the basolateral sorting of mCAT1 is still unclear. It has been shown that on the surface of eMuLV-infected cells, expression of mCAT1 was reduced apparently through posttranslational mechanisms (Kim and Cunningham, 1993; Wang et al., 1996) . However, the molecular events that lead to this phenomenon still remain unknown.
In order to study posttranslational regulation of mCAT1 expression, we established mCAT1-GFP-expressing MDCK cells (MDCK/mCAT1) and compared expression and subcellular localization of the fusion protein in the absence and presence of eMuLV infection. We also analyzed interaction of mCAT1 with clathrin adaptor protein (AP) complexes involved in posttranslational protein trafficking. In the absence of eMuLV infection, expression of mCAT1 on the basolateral surface of polarized MDCK cells was confirmed, and association of mCAT1 with clathrin adaptor protein complex 1 (AP-1) was detected. AP-1 is implicated in protein trafficking from trans-Golgi network (TGN) to the basolateral surface of polarized epithelial cells (Folsch et al., 1999) . When the cells were productively infected with eMuLV, cell surface expression of mCAT1-GFP was reduced. Concomitantly, association of mCAT1 with AP-1 was also decreased. In contrast, association of mCAT1 with AP-3 was clearly increased in eMuLV-infected MDCK/mCAT1 cells. AP-3 has been shown to be involved in protein sorting from TGN to lysosomes (Peden et al., 2004) . When eMuLV envelope (Env) protein alone was expressed in the cells, similar results were obtained. These results are discussed in relationship to the mechanism by which eMuLV infection might affect the expression of its cognate receptor.
Results
mCAT1 is expressed on the basolateral surface of MDCK cells and physically associated with clathrin adaptor complex 1 (AP-1)
To investigate subcellular localization of mCAT1 in epithelial cells, we transfected MDCK cells with the vector pmCAT1-GFP (Masuda et al., 1999) , and G418-resistant cell clones were isolated. Cell surface expression of mCAT1-GFP was clearly detected in most clones, and at least two representative clones were used for further analysis. Laser scanning confocal microscopy of the cells grown on a collagen-coated permeable supports revealed honey-comb like green fluorescence distribution representing cell surface expression of mCAT1-GFP (Fig. 1A) . Cytoplasmic granular distribution was also observed (Fig. 1A) . X-Z scans of the cells revealed that mCAT1-GFP was distributed on the basolateral surface of the cells (Fig. 1B,  mCAT1 ), confirming the previous report (Kizhatil and Albritton, 2003) . Staining the cells with an antibody to ZO-1, a component of the tight junction (Stevenson et al., 1986) , demonstrated that mCAT1-GFP was expressed on the cell surface up to, but not above, the tight junctions (Fig. 1B, ZO-1 and Merge). Since GFP by itself showed homogeneous distribution in MDCK cells (data not shown), basolateral expression of mCAT1-GFP was most likely due to specific trafficking mechanism acting on mCAT1. Since AP-1 has been shown to be involved in transport of cellular proteins from TGN to the basolateral membrane of polarized epithelial cells (Folsch et al., 1999) , we examined interaction of mCAT1-GFP with AP-1. Immunoprecipitation (IP) with an anti-GFP antibody followed by Western blotting revealed that mCAT1-GFP was physically associated with γ-adaptin, an integral component of AP-1 (Fig. 1C, lane 1) . Interaction of the control GFP with AP-1 was not detected (Fig.  1C, lane 2) . Therefore, it is most likely that mCAT1 is associated with AP-1.
eMuLV infection reduces cell surface expression of mCAT1
Canine MDCK cells are resistant to eMuLV infection. In contrast, MDCK/mCAT1 were susceptible to transduction with a lacZ gene-bearing eMuLV vector (data not shown). Therefore, mCAT1-GFP expressed in MDCK cells functioned as a receptor for eMuLV infection. Taking this advantage, we examined the effects of eMuLV infection on mCAT1-GFP expression. MDCK/mCAT1 cells were infected with ecotropic PVC-211 MuLVat a multiplicity of infection (MOI) of 1.0 and observed by laser scanning confocal microscopy. When the cells were stained with an anti-Rauscher SU gp70 antiserum, which recognizes eMuLV envelope surface protein (SU), at 5 days post-infection (dpi), cells expressing different levels of SU were detected in the culture. There was a tendency that the intensity of mCAT1-GFP fluorescence was weak in the cells expressing high levels of SU ( Fig. 2A) , whereas the mCAT1-GFP fluorescence was clearly visible in the cells whose SU levels were low. Compatibly, flow cytometric analysis demonstrated that the levels of mCAT1-GFP fluorescence were decreased in the eMuLV-infected SU-positive cells (Fig. 2B, eMuLV) . In contrast, amphotropic MuLV 4070A (aMuLV), which infects MDCK cells without using mCAT1 as a receptor, failed to affect the levels of mCAT1-GFP fluorescence (Fig. 2B, aMuLV) . X-Z scans of eMuLV-infected cells demonstrated expression of eMuLV SU on the apical membranes, and mCAT1-GFP fluorescence was decreased in these cells (Fig. 2C) . Expression of another basolateral protein, E-cadherin, was not affected in eMuLV SU-positive cells (data not shown), suggesting that basolateral expression of mCAT1 was specifically downregulated by eMuLV infection. Apical expression of SU was also confirmed by X-Y scans of the apical surface of the eMuLV infected cell monolayer (Fig. 2D, AM) .
N-linked glycosylation of mCAT1 is altered in eMuLV-infected MDCK
Western blot analysis of the total cell lysates with an anti-GFP antibody revealed that the molecular mass of mCAT1-GFP in MDCK cells was around 97 kDa (Fig. 3 , lane 1). The higher band around 190 kDa may correspond to the SDS-resistant dimer described previously (Masuda et al., 1999) or an aggregated form. In the eMuLV-infected cells, the molecular mass of mCAT1-GFP appeared to be decreased to about 82 kDa with a higher band around 160 kDa (Fig. 3, lane 2) . Removal of N-linked sugars with Peptide: N-Glycosidase F revealed that the molecular weights of the protein backbone of mCAT1-GFP were the same in uninfected and eMuLV-infected cells (Fig. 3 , lanes 3 and 4), indicating that the mass discrepancy was due to difference in N-linked glycosylation. Since GFP is not known to be modified by glycosylation, N-linked glycosylation of mCAT1 appears to be affected by eMuLV infection in MDCK cells.
Patterns of interaction between mCAT1 and clathrin adaptor complexes are altered by eMuLV infection
Reduced expression and incomplete glycosylation of mCAT1-GFP in eMuLV-infected cells raised the possibility that posttranslational trafficking of mCAT1 might be affected. To address this issue, we first carried out laser scanning confocal microscopy for comparing distribution of mCAT1-GFP with that of the AP complexes of different classes known to be involved in protein trafficking through distinct pathways. In mock-infected MDCK/mCAT1 cells, distribution of AP-1 in the juxtanuclear region overlapped with that of mCAT1-GFP (Fig. 4A, Mock) . This is compatible with the results of IP-western experiments showing physical association of mCAT1 with AP-1 (Fig. 1C) . Also, AP-2 appeared to be colocalized with mCAT1-GFP mainly on the plasma membrane (Fig. 4B, Mock) . Patterns of staining with an antibody to δ-adaptin, an integral component of AP-3, was marginally colocalized with mCAT1-GFP (Fig. 4C , Mock). When MDCK/mCAT1 cells were infected with eMuLV at a MOI of 1.0 and observed at 5 dpi, surface expression of mCAT1-GFP was generally decreased. Concomitantly, colocalization of mCAT1-GFP with AP-1 became less obvious (Fig.  4A , eMuLV) compared with that in the mock-infected cells. Colocalization of mCAT1-GFP and AP-2 became more apparent in the cytoplasm than on the cell surface. Colocalization of mCAT1-GFP with AP-3 became clearly detectable in eMuLVinfected cells mainly in the cytoplasm. The observation was especially notable in the cells whose mCAT1-GFP surface expression was markedly decreased (Fig. 4C, eMuLV) .
Then, effects of eMuLV infection on the physical association between mCAT1 and the AP complexes were examined. MDCK/mCAT1 cells were infected with eMuLV at a MOI of 1.0, and the cell lysates were prepared at 3, 7, and 10 dpi.
Overall levels of AP-1, AP-2, and AP-3 did not appear to be significantly changed by eMuLV infection (Fig. 5A) . However, IP-western analysis revealed that the degree of association between mCAT1 and AP-1 was clearly decreased in eMuLVinfected cells in a time-dependent manner (Figs. 5B and C). Association of mCAT1 with AP-2 appeared to remain constant in the absence and presence of eMuLV infection (Figs. 5B and  C) . In contrast, the association between mCAT1 and AP-3 was gradually increased through 3 to 10 dpi (Figs. 5B and C) . These results were compatible with the observation made by confocal microscopy (Fig. 4) .
eMuLV Env precursor protein is physically associated with mCAT1 and reduces cell surface expression of mCAT1, affecting association between mCAT1 and AP complexes
To determine the viral factor responsible for mCAT1 downregulation, we compared distribution of mCAT1 in the cells with that of eMuLV proteins. As mentioned above, cells with different levels of SU expression were observed in the culture. When the cells with a moderate level of Env expression were examined, fluorescence of mCAT1-GFP was still detectable, and colocalization of mCAT1 with the viral Env protein was detected mainly in the cytoplasm (Fig. 6A) . Consistently, IP with an anti-GFP antibody followed by Western blot analysis with an anti-SU antibody demonstrated physical association between mCAT1 and eMuLV Env protein (Fig. 6B ). Since association with not only SU but also eMuLV Env precursor protein gPr80 was detected, it is suggested that association between mCAT1 and eMuLV Env protein could take place before proteolytic processing of the latter one. Neither colocalization nor association of mCAT1 with viral Gag protein was detected (data not shown).
To examine effects of eMuLV Env alone on mCAT1 expression, MDCK/mCAT1 cells were transfected with a plasmid vector expressing Moloney MuLV Env protein. Expression of the viral Env protein was confirmed by immunostaining with an anti-SU antibody (data not shown). Flow cytometry showed that expression of the eMuLV Env protein alone could decrease mCAT1-GFP fluorescence although the control plasmid, pcDNA3.1/Zeo, had no effect (Fig. 7A) . In the eMuLV Envexpressing cells, association of mCAT1 with AP-1 was markedly decreased whereas the association with AP-3 was increased (Fig. 7B) .
Discussion
It has previously been shown that the system y + transport activity is present on the basolateral surface of polarized epithelial cells (Barahona and Bravo, 1993; Qian et al., 2003) . Consistently, Kizhatil and Albritton demonstrated basolateral expression of mCAT1 in polarized MDCK cells (Kizhatil and Albritton, 2003) . However, the mechanism responsible for the basolateral expression of mCAT1 has been unknown. Using the mCAT1-GFP fluorescent molecule, we not only confirmed distribution of mCAT1 on the basolateral surface of MDCK cells, but also demonstrated the association of mCAT1 with AP-1. Epithelial cell-specific AP-1 containing μ1B subunit is 1 and 3) or eMuLV-infected (lanes 2 and 4) were prepared at 5 dpi and treated without (lanes 1 and 2) or with (lanes 3 and 4) PNGaseF before Western blot analysis with an anti-GFP antibody.
essential for the basolateral localization of transmembrane proteins, such as vesicular stomatitis virus glycoprotein G, transferrin receptor, and low density lipoprotein receptor (Folsch et al., 1999 (Folsch et al., , 2001 (Folsch et al., , 2003 . Therefore, it is possible that AP-1 plays a role in intracellular trafficking of mCAT1 as well. In this study, we also detected constant association of mCAT1 with AP-2 involved in clathrin-coated pit-mediated endocytosis (Traub, 2003) . Therefore, cell surface mCAT1 expressed on the MDCK cell surface might be internalized through clathrin-coated-pitmediated endocytosis. It has been shown by using human 293 cells expressing mCAT1-GFP that entry of eMuLV can occur independently of the clathrin-coated-pit-mediated endocytic pathway (Lee et al., 1999) . Corroboratively, it has been shown by using baby hamster kidney fibroblastic cells that mCAT1 is associated with caveolin, suggesting the functional importance of caveolae-madiated pathway in eMuLV entry (Lu and Silver, 2000) . However, it has been shown that a majority of mCAT1 expressed in MDCK cells does not colocalize with caveolin (Kizhatil and Albritton, 2003) . Further studies are necessary to determine whether clathrin-coated-pit-mediated pathway could be involved in eMuLV entry into MDCK cells.
eMuLV infection and eMuLV Env expression have been shown to affect N-linked glycosylation and cell surface expression of mCAT-1 (Kim and Cunningham, 1993; Wang et al., 1996) . Our present study using mCAT1-GFP fluorescent molecule generated comparable results. The results are compatible with the possibility that in eMuLV-infected cells, mCAT1 fails to be carried on the trafficking pathway from TGN to the cell surface through which glycosylation modification is completed. Since our data showed colocalization and association of eMuLV Env and mCAT1-GFP, it is suggested that eMuLV Env might directly affect intracellular trafficking of mCAT1, leading to downregulation of the receptor expression. Exact mechanism by which eMuLV Env affects the receptor trafficking is unclear. However, our data suggest that the effects of eMuLV Env on association between mCAT1 and AP complexes may play some role. In the presence of eMuLV Env, association of mCAT1 with AP-3 was increased while the association with AP-1 was decreased. AP-3 is known to be localized to endosomes and needed for protein targeting from cell surface or TGN to lysosomes (Peden et al., 2004) . Therefore, it is possible that eMuLV Env affects the interaction between mCAT1 and AP complexes so that basolateral trafficking and lysosomal degradation of mCAT1 are inhibited and enhanced, respectively. Although it is unknown how eMuLV could affect mCAT1-AP complexes interaction, it is tempting to speculate that through direct binding, eMuLV modifies the conformation of mCAT1 in such a manner that a motif recognized by AP-3, but not AP-1, can be exposed. Since typical motifs for AP-1 or AP-3 recognition are not found in mCAT1, additional studies are necessary to test this possibility.
Mechanism for receptor downregulation has extensively been studied for a complex retrovirus, human immunodeficiency virus type 1 (HIV-1), leading to the observations that multiple HIV proteins, such as Nef, Vpu and Env gp160, are involved (Lu et al., 1998; Geyer et al., 2002; Piguet et al., 1998; Preusser et al., 2001; Bour et al., 1995; Crise et al., 1990; Craig et al., 2000) . In contrast, eMuLV, a simple retrovirus, may have evolved in such a way that each viral protein accommodates multiple functions so that viral replication and propagation can be optimized. Among the eMuLV Env molecules expressed in MDCK cells, those that did not show colocalization with mCAT1 were mainly detected on the apical surface of MDCK cells. In our preliminary study, MDCK/ mCAT1 cells chronically infected with eMuLV were grown on the permeable support. When the virus product by the cells was examined, virus yield in the compartment above the support was higher than that in the compartment below the support (data not shown). Therefore, newly synthesized viral particles appear to be released preferentially from the apical surface of MDCK cells. Through the history of viral evolution, eMuLV Env may have obtained the properties that it can utilize the molecules on the basolateral surface of epithelial cells as a receptor, modulate intracellular trafficking of the receptor to induce receptor downregulation, and be transported to the apical surface of the cells to enhance virion release from the area lacking the receptor.
Materials and methods

Cells, plasmids, and transfection
MDCK cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. The plasmid pmCAT1 encoding mCAT1-GFP was described previously (Masuda et al., 1999) . For transfection, MDCK cells were seeded at a density of 2 × 10 5 in 60 mm culture dishes. Next day, cells were added with a mixture of pmCAT1 (2 μg) and FUGENE 6 (Roche Diagnostics). Then, the cells were grown in the selective medium containing 800 μg/ml of G418 (Invitrogen). Cell clones expressing mCAT1-GFP (MDCK/ mCAT1) were identified by Olympus IX70 fluorescence microscope and isolated using stainless-steel cylinders. All experiments were performed using at least two independent clones expressing high levels of mCAT1-GFP between passage numbers 5 and 20 after cloning. Plasmid for expressing eMuLV Env was constructed by inserting the PmlI-AflII fragment of Moloney MuLV clone 48 (Bacheler and Fan, 1981) into the polylinker site of pcDNA3.1/Zeo. MCDK/mCAT1 cells were transfected with the plasmid as described above, and the transformants were selected by Zeocin (200 μg/ml).
Antibodies
Monoclonal antibodies to γ-adaptin (clone 100/3) and α-adaptin (clone 100/2) were purchased from Sigma-Aldrich. Monoclonal antibodies to E cadherin (clone 36), γ-adaptin (clone 88), α-adaptin (clone 8) and δ-adaptin (clone 18) were purchased from Transduction Laboratories. Anti-GFP monoclonal antibody (clone 1E4) and rabbit anti-GFP polyclonal antiserum were purchased from Medical and Biological Laboratories. Rabbit anti-ZO-1 polyclonal antibody was purchased from Zymed Laboratories. Monoclonal antibodies to eMuLV SU (clone 720) (Chesebro et al., 1983) and Gag MA (clone 34) (Chesebro et al., 1981) were given by B. Chesebro (Laboratory of Persistent Viral Diseases, National Institute of Allergy and Infectious Diseases). A goat antiserum against Rauscher MuLV SU was purchased from ViroMED Biosafety Laboratories. TRITC-conjugated antibodies to mouse and rabbit IgG and PE-conjugated anti-rabbit IgG antibody were from Jackson ImmunoResearch. R-phycoerythrin-conjugated F(ab′) 2 antibody specific to mouse IgG was from DAKO. Horseradish peroxidase (HRP)-conjugated antibodies to mouse, goat and rabbit IgG were from Amersham Biosciences.
Retrovirus infections
MDCK/mCAT1 cells were seeded at a density of 1 × 10 5 cells per 60-mm dish and infect with PVC-211 eMuLV (Masuda et al., 1992) or 4070A aMuLV (Hartley and Rowe, 1976 ) at a MOI of 1.0 in the presence of polybrene (5 μg/ml).
Immunofluorescent staining of MDCK cells
Cells were grown to confluence on collagen-coated 12-mm permeable supports (Corning Costar). After fixation with 4% ice-cold paraformaldehyde for 20 min, cells were washed and permeabilized with 0.5% Triton X-100 in phosphate-buffered balanced salt solution (Triton/PBS) at room temperature for 15 min. Cells were then washed and incubated with primary antibodies at the appropriate dilution for 1 h at room temperature or overnight at 4°C. Then, the cells were rinsed with Triton/PBS, incubated with secondary antibodies for 1 h at room temperature, and washed again. The cells on the permeable supports were mounted on glass slides in FluoroGuard antifade regent (BioRad) and analyzed by laser scanning confocal microscopy using Olympus FV500 or Leica TCS-SP2. Optical sections were obtained under a 63× oil-immersion objective lens, at a definition of 512 × 512 pixels, adjusting the pinhole diameter to 1 airy unit for each emission channel.
Flow cytometry
Cells detached from the culture flasks by trypsin-EDTA were reacted with anti-SU antibody or anti-MA antibody as described previously (Fujisawa et al., 1997) . The cells were stained with R- Fig. 5 . Effects of eMuLV infection on the interaction between mCAT1 and the clathrin adaptor complexes. MDCK/mCAT1 cells were mock-infected or infected with eMuLV, and the cell lysates were prepared at 3, 7 and 10 dpi. (A) The lysates were subjected to Western blot analysis with an antibody to γ-adaptin (AP-1), α-adaptin (AP-2), or δ-adaptin (AP-3). (B) The lysates were immunoprecipitated with an anti-GFP antibody and subjected to Western blot analysis with an antibody to γ-adaptin (AP-1), α-adaptin (AP-2), δ-adaptin (AP-3), or GFP. (C) Intensities of the bands in panel B were quantitatively analyzed by Image J, and the amounts of the AP complex components co-immunoprecipitated with mCAT1-GFP were normalized based on the level of mCAT1-GFP in order to compare the degrees of association. One hundred percent corresponds to the association in the mock-infected cells.
phycoerythrin-conjugated F(ab′) 2 fragment of goat anti-mouse IgG antibody. Then, the stained cells were analyzed with a FACSCalibur (Becton Dickinson), and the data were collected in the log mode. Ten thousand cells were analyzed for each sample.
Protein analysis
Cells grown to confluence on 6-well plates (FALCON) were washed once with Hunks' balanced salt solution (Invitrogen), and 1.25 ml of ice-cold lysis buffer containing 10 mM Tris-HCl (pH 7.4), 2.5% Triton X-100 and protease inhibitor cocktail (Roche Diagnostics) was added to each well. The cell lysates were collected with a cell scraper and passed four times through a 22-gauge needle. Then the samples were incubated on ice for 30 min and subjected to centrifugation at 15,000 rpm, 4°C, for 15 min. The supernatants were collected, and the protein concentration was measured by using the Bio-Rad Protein Assay. For IP, the lysates containing 200 μg of protein were added with an anti-GFP monoclonal antibody and incubated overnight at 4°C. Then, the samples were further incubated with immobilized Protein-G (PIERCE) another overnight. Precipitated samples were washed three times with lysis buffer containing 1% Triton X-100 and twice with the buffer without Triton X-100 and dissolved in the sample buffer containing 2% sodium dodecyl sulfate and 5% 2-mercaptoethanol. The samples were then boiled for 5 min, subjected to electrophoresis in 4 to 12% gradient polyacrylamide gels (NuPAGE; Invitrogen) and electro-transferred to Immobilon-P membranes (Millipore). After treatment with 10% skim milk in 0.05 M Tris-HCl (pH 8.0) containing 0.05% Tween 20 (TBS-T), the membranes were incubated with primary antibodies at 4°C overnight. Next day, the membranes were rinsed with TBS-T and reacted with HRP-conjugated secondary antibodies for visualization of the signals with Lumi-Light PLUS (Roche Diagnostics). For quantitative analysis of the results, intensities of the bands on the film were digitized and analyzed by Image J 1.33u (Wayne Rasband, National Institutes of Health, U.S.A.). In some experiments, 500 U of Peptide: N-Glycosidase F (PNGase F; New England Biolabs) was added to the cell lysates in a final MDCK/mCAT1 cells were mock-infected or infected with eMuLV, and the cell lysates were prepared at 3, 7, and 10 dpi for Western blot analysis with an anti-SU antibody (WB). A part of cell lysates was immunoprecipitated with an anti-GFP antibody and then subjected to Western blot analysis with an anti-SU antibody (IP). ⁎ : eMuLV Env precursor protein (gPr80). ⁎⁎ : eMuLV SU. volume of 25 μl containing 1% NP-40 and 0.05 M sodium phosphate (pH 7.5) and incubated at 37°C for 2 h prior to gel electrophoresis.
